Role of USF1 in activating CYBA transcription and influencing NADPH-ROS-mediated oxidative stress and lipid accumulation in non-alcoholic fatty liver disease
- PMID: 39577491
- DOI: 10.1016/j.bbalip.2024.159581
Role of USF1 in activating CYBA transcription and influencing NADPH-ROS-mediated oxidative stress and lipid accumulation in non-alcoholic fatty liver disease
Abstract
Nonalcoholic fatty liver disease (NAFLD) progression is relevant to oxidative stress, while NADPH oxidase can produce ROS. This study explored how the upstream stimulatory factor 1 (USF1) regulates cytochrome b-245 alpha chain (CYBA) expression through the NADPH-ROS pathway and its impact on oxidative stress and lipid accumulation in NAFLD. Bioinformatics analysis identified CYBA as a gene with altered expression in NAFLD. Mouse and cell models of NAFLD were established through high-fat diet (HFD) and palmitic acid (PA) treatment respectively. CYBA and USF1 expression was modulated using RNA interference, and their effects on NAFLD progression were then examined. ChIP and dual-luciferase reporter assays were performed to confirm the transcriptional regulation of CYBA by USF1. Elevated CYBA expression was observed in NAFLD. Reduced NADPH oxidase activity, oxidative stress, lipid accumulation, and inflammation were observed in NAFLD models after knocking down CYBA. USF1 was found to bind to the CYBA promoter and activate its transcription. Similar effects as CYBA knockdown on NAFLD were achieved by knocking down USF1. The protective impacts of USF1 silencing on NAFLD were reversed by overexpressing CYBA. In summary, this study demonstrates that USF1 mediates the transcriptional activation of CYBA, increasing NADPH-ROS-derived oxidative stress and lipid accumulation in NAFLD.
Keywords: CYBA; Lipid accumulation; Non-alcoholic fatty liver disease; Oxidative stress; USF1.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.Int Immunopharmacol. 2022 Mar;104:108306. doi: 10.1016/j.intimp.2021.108306. Epub 2022 Jan 6. Int Immunopharmacol. 2022. PMID: 34999396
-
Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway.Biochem Pharmacol. 2024 Dec;230(Pt 2):116594. doi: 10.1016/j.bcp.2024.116594. Epub 2024 Oct 26. Biochem Pharmacol. 2024. PMID: 39490677
-
Upstream stimulating factor 1 suppresses autophagy and hepatic lipid droplet catabolism by activating mTOR.FEBS Lett. 2018 Aug;592(16):2725-2738. doi: 10.1002/1873-3468.13203. Epub 2018 Aug 16. FEBS Lett. 2018. PMID: 30054905 Free PMC article.
-
Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD.Food Funct. 2021 May 11;12(9):3898-3918. doi: 10.1039/d0fo02736g. Food Funct. 2021. PMID: 33977953
-
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.Free Radic Biol Med. 2020 May 20;152:116-141. doi: 10.1016/j.freeradbiomed.2020.02.025. Epub 2020 Mar 8. Free Radic Biol Med. 2020. PMID: 32156524 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical